study objective prospective study undertaken assess efficacy toxicity conformal radiotherapy medically inoperable cell lung cancer design eligible patients clinical stage iiia cell lung cancer candidates surgical resection medical reasons patient refusal patients adequate cardiopulmonary function received NUMBER gy mediastinum gross tumor volume photons concurrent proton boost gross tumor volume additional NUMBER cobalt gray equivalents cge total tumor dose NUMBER cge given NUMBER weeks patients poor cardiopulmonary function received radiotherapy gross tumor volume NUMBER cge given NUMBER fractions period results patients treated study july NUMBER march NUMBER clinical staging patients follows stage NUMBER patients stage ii NUMBER patients stage iiia NUMBER patients eighteen patients received combination protons x rays NUMBER patients received radiation evaluable patients ranged NUMBER NUMBER months median NUMBER months patients proton photon arm developed pneumonitis resolved oral steroids significant toxicities encountered actuarial survival NUMBER years entire group NUMBER stage patients survival NUMBER years NUMBER local disease control NUMBER conclusion preliminary results study indicate radiotherapy used safely group patients survival local control appear good compare favorably published reports utilizing conventional photon irradiation proton beam early stage non small non small proton beam NUMBER week thirty seven proton beam follow disease free disease free proton beam disease free